Catalyst Wire Dossier Catalyst Wire Dossier

RMT

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RMT, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial [Phase 2]

See pricing